Human Immunity and Blood

Interleukin-1 is a cytokine that is produced by macrophages, dendritic cells, and other immune cells. It stimulates the production of tumor necrosis factor by macrophages, which is important for controlling infections and promoting inflammation.

Interleukin-6 is a cytokine that is produced by fibroblasts, macrophages, and other cells. It stimulates the production of granulocyte-macrophage colony-stimulating factor by fibroblasts, which is important for the production of neutrophils and macrophages.

Interleukin-6 is a cytokine that is produced by hepatocytes, macrophages, and other cells. It stimulates the production of hepatocyte growth factor by hepatocytes, which is important for the regeneration of liver tissue.

Interleukin-4 is a cytokine that is produced by activated T helper cells and other immune cells. It stimulates the production of platelet-derived growth factor by platelets, which is important for the healing of wounds.

Interleukin-8 is a cytokine that is produced by macrophages, neutrophils, and other cells. It stimulates the production of vascular endothelial growth factor by endothelial cells, which is important for the growth of new blood vessels.

Interleukin-10 is a cytokine that is produced by regulatory T cells and other immune cells. It stimulates the production of transforming growth factor-beta by T cells, which is important for the regulation of immune responses and the healing of wounds.

Interleukin-1 is a cytokine that is produced by macrophages, dendritic cells, and other immune cells. It stimulates the production of fibroblast growth factor by fibroblasts, which is important for the healing of wounds and the growth of new tissue.

Viral antigens are not typically considered tumor antigens, as they are associated with viral infections rather than cancer.

Dendritic cells are specialized antigen-presenting cells that capture, process, and present antigens to T cells, initiating an immune response.

Immune checkpoint inhibitors work by blocking inhibitory receptors on T cells, such as PD-1 and CTLA-4, thereby releasing the brakes on T cell activity and enhancing anti-tumor immune responses.

Immune surveillance refers to the immune system's ability to continuously monitor and eliminate abnormal or potentially cancerous cells, preventing tumor development.

Interferon-gamma (IFN-γ) is a key cytokine that promotes the differentiation of naive T cells into Th1 cells, which are important for cell-mediated immunity and anti-tumor responses.

Immune evasion refers to the strategies employed by tumor cells to avoid detection and elimination by the immune system, such as downregulating antigen expression or expressing inhibitory molecules.

Natural killer (NK) cells are cytotoxic lymphocytes that can kill tumor cells through ADCC, a process in which antibodies bound to tumor cells recruit NK cells to mediate cell lysis.

Immune exhaustion is a state of T cell dysfunction characterized by impaired effector function, reduced cytokine production, and upregulation of inhibitory receptors, often occurring in chronic infections or cancer.